In particular, low SHBG more than testosterone levels seem to be associated with hepatic steatosis, suggesting that bioavailable, free testosterone and SHBG levels can be considered early biomarkers for NAFLD development [38,140,431,432]. This evidence concerns the gene SHBG and Hepatic steatosis.